Federated Hermes, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Federated Hermes, Inc.
- $50.2 Billion
- Q2 2025
A detailed history of Federated Hermes, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 11,224 shares of AMPH stock, worth $340,648. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,224
Previous 585,115
98.08%
Holding current value
$340,648
Previous $17 Million
98.48%
% of portfolio
0.0%
Previous 0.04%
Shares
32 transactions
Others Institutions Holding AMPH
# of Institutions
256Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$81.5 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$61.8 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$49.4 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$47.8 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.49B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...